164 related articles for article (PubMed ID: 36046692)
1. Hyperhomocysteinemia Promotes Cardiac Hypertrophy in Hypertension.
Deng Y; Li Z; An X; Fan R; Wang Y; Li J; Yang X; Liao J; Xia Y
Oxid Med Cell Longev; 2022; 2022():1486157. PubMed ID: 36046692
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy.
Lunde IG; Aronsen JM; Melleby AO; Strand ME; Skogestad J; Bendiksen BA; Ahmed MS; Sjaastad I; Attramadal H; Carlson CR; Christensen G
Mol Biol Rep; 2022 Dec; 49(12):11795-11809. PubMed ID: 36205855
[TBL] [Abstract][Full Text] [Related]
3. Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy.
Luo Y; Jiang N; May HI; Luo X; Ferdous A; Schiattarella GG; Chen G; Li Q; Li C; Rothermel BA; Jiang D; Lavandero S; Gillette TG; Hill JA
Circulation; 2021 Jul; 144(1):34-51. PubMed ID: 33821668
[TBL] [Abstract][Full Text] [Related]
4. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
[TBL] [Abstract][Full Text] [Related]
5. Normalization of the calcineurin pathway underlies the regression of hypertensive hypertrophy induced by Na+/H+ exchanger-1 (NHE-1) inhibition.
Ennis IL; Garciarena CD; Escudero EM; Pérez NG; Dulce RA; Camilión de Hurtado MC; Cingolani HE
Can J Physiol Pharmacol; 2007; 85(3-4):301-10. PubMed ID: 17612638
[TBL] [Abstract][Full Text] [Related]
6. TRPC4α and TRPC4β Similarly Affect Neonatal Cardiomyocyte Survival during Chronic GPCR Stimulation.
Kirschmer N; Bandleon S; von Ehrlich-Treuenstätt V; Hartmann S; Schaaf A; Lamprecht AK; Miranda-Laferte E; Langsenlehner T; Ritter O; Eder P
PLoS One; 2016; 11(12):e0168446. PubMed ID: 27992507
[TBL] [Abstract][Full Text] [Related]
7. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
[TBL] [Abstract][Full Text] [Related]
8. Low Dose of Folic Acid Can Ameliorate Hyperhomocysteinemia-Induced Cardiac Fibrosis and Diastolic Dysfunction in Spontaneously Hypertensive Rats.
Cao P; Zhang W; Wang G; Zhao X; Gao N; Liu Z; Xu R
Int Heart J; 2021 May; 62(3):627-635. PubMed ID: 33994505
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.
Grebe C; Klingebiel TM; Grau SP; Toischer K; Didié M; Jacobshagen C; Dullin C; Hasenfuss G; Seidler T
Cardiovasc Res; 2011 Jun; 90(3):521-8. PubMed ID: 21273244
[TBL] [Abstract][Full Text] [Related]
10. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy.
Cai B; Tan X; Zhang Y; Li X; Wang X; Zhu J; Wang Y; Yang F; Wang B; Liu Y; Xu C; Pan Z; Wang N; Yang B; Lu Y
Stem Cells Transl Med; 2015 Dec; 4(12):1425-35. PubMed ID: 26586774
[TBL] [Abstract][Full Text] [Related]
12. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
[TBL] [Abstract][Full Text] [Related]
13. Gestational diabetes triggers postpartum cardiac hypertrophy via activation of calcineurin/NFAT signaling.
Verma N; Srodulski S; Velmurugan S; Hoskins A; Pandey VK; Despa F; Despa S
Sci Rep; 2021 Oct; 11(1):20926. PubMed ID: 34686739
[TBL] [Abstract][Full Text] [Related]
14. Cisapride protects against cardiac hypertrophy via inhibiting the up-regulation of calcineurin and NFATc-3.
Zhou X; Zhang Q; Zhao T; Bai X; Yuan W; Wu Y; Liu D; Li S; Ju J; Chege Gitau S; Chu W; Xu C; Lu Y
Eur J Pharmacol; 2014 Jul; 735():202-10. PubMed ID: 24769415
[TBL] [Abstract][Full Text] [Related]
15. Folic acid attenuates hyperhomocysteinemia-induced glomerular damage in rats.
Cao L; Lou X; Zou Z; Mou N; Wu W; Huang X; Tan H
Microvasc Res; 2013 Sep; 89():146-52. PubMed ID: 23859838
[TBL] [Abstract][Full Text] [Related]
16. Involvement of calcium-sensing receptor in cardiac hypertrophy-induced by angiotensinII through calcineurin pathway in cultured neonatal rat cardiomyocytes.
Wang LN; Wang C; Lin Y; Xi YH; Zhang WH; Zhao YJ; Li HZ; Tian Y; Lv YJ; Yang BF; Xu CQ
Biochem Biophys Res Commun; 2008 May; 369(2):584-9. PubMed ID: 18295598
[TBL] [Abstract][Full Text] [Related]
17. Testin protects against cardiac hypertrophy by targeting a calcineurin-dependent signalling pathway.
Gao L; Liu Y; Guo S; Xiao L; Liang C; Wang X
J Cell Mol Med; 2019 Jan; 23(1):328-339. PubMed ID: 30467953
[TBL] [Abstract][Full Text] [Related]
18. Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signaling.
Gao H; Wang F; Wang W; Makarewich CA; Zhang H; Kubo H; Berretta RM; Barr LA; Molkentin JD; Houser SR
J Mol Cell Cardiol; 2012 Nov; 53(5):657-67. PubMed ID: 22921230
[TBL] [Abstract][Full Text] [Related]
19. The protective mechanism of folic acid on hyperhomocysteinemia-related arterial injury in spontaneously hypertensive rats: Folic acid against arterial inflammation.
Zhang L; Li Z; Xing C; Ma X; Xu R
Vascular; 2022 Oct; 30(5):988-998. PubMed ID: 34362270
[TBL] [Abstract][Full Text] [Related]
20. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
